The adjuvant effect of interleukin-12 in a vaccine against Leishmania major - PubMed (original) (raw)

. 1994 Jan 14;263(5144):235-7.

doi: 10.1126/science.7904381.

Affiliations

• PMID: 7904381
• DOI: 10.1126/science.7904381

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major

L C Afonso et al. Science. 1994.

Abstract

Protection induced by vaccination depends on the capacity of the vaccine to elicit an appropriate immune response. In leishmaniasis, protection requires leishmanial-specific CD4+ T helper (TH) cells. Vaccination of BALB/c mice with leishmanial antigens and interleukin-12 (IL-12) promoted the development of leishmanial-specific CD4+ TH1 cells. These mice were resistant to subsequent infection with Leishmania major. Thus, IL-12 is an effective adjuvant for the initiation of protective cell-mediated immunity against leishmaniasis and may be an important component in other vaccines that need to induce cell-mediated immunity.

PubMed Disclaimer

Similar articles

• A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB/c mice from Leishmania major infection.
  Yamakami K, Akao S, Sato M, Nitta Y, Miyazaki J, Tadakuma T. Yamakami K, et al. Parasitol Int. 2001 Jul;50(2):81-91. doi: 10.1016/s1383-5769(01)00070-8. Parasitol Int. 2001. PMID: 11438430
• LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
  Skeiky YA, Kennedy M, Kaufman D, Borges MM, Guderian JA, Scholler JK, Ovendale PJ, Picha KS, Morrissey PJ, Grabstein KH, Campos-Neto A, Reed SG. Skeiky YA, et al. J Immunol. 1998 Dec 1;161(11):6171-9. J Immunol. 1998. PMID: 9834103
• What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?
  Campos-Neto A. Campos-Neto A. Braz J Med Biol Res. 2005 Jul;38(7):979-84. doi: 10.1590/s0100-879x2005000700001. Epub 2005 Jul 4. Braz J Med Biol Res. 2005. PMID: 16007269 Review.
• The immunology of susceptibility and resistance to Leishmania major in mice.
  Sacks D, Noben-Trauth N. Sacks D, et al. Nat Rev Immunol. 2002 Nov;2(11):845-58. doi: 10.1038/nri933. Nat Rev Immunol. 2002. PMID: 12415308 Review.

Cited by

• High levels of FCγR3A and PRF1 expression in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
  Li S, Ma D, Zhang L, Li X, Deng C, Qin X, Zhang T, Wang L, Shi Q, Wang Q, Wu Q, Zhang X, Zhang F, Li Y. Li S, et al. Dig Dis Sci. 2013 Feb;58(2):458-64. doi: 10.1007/s10620-012-2456-1. Epub 2012 Nov 23. Dig Dis Sci. 2013. PMID: 23179144
• Differential inhibitory mechanism of cyclic AMP on TNF-alpha and IL-12 synthesis by macrophages exposed to microbial stimuli.
  Procópio DO, Teixeira MM, Camargo MM, Travassos LR, Ferguson MA, Almeida IC, Gazzinelli RT. Procópio DO, et al. Br J Pharmacol. 1999 Jul;127(5):1195-205. doi: 10.1038/sj.bjp.0702624. Br J Pharmacol. 1999. PMID: 10455266 Free PMC article.
• Constitutive beta cell expression of IL-12 does not perturb self-tolerance but intensifies established autoimmune diabetes.
  Holz A, Brett K, Oldstone MB. Holz A, et al. J Clin Invest. 2001 Dec;108(12):1749-58. doi: 10.1172/JCI13915. J Clin Invest. 2001. PMID: 11748258 Free PMC article.
• Beryllium, an adjuvant that promotes gamma interferon production.
  Lee JY, Atochina O, King B, Taylor L, Elloso M, Scott P, Rossman MD. Lee JY, et al. Infect Immun. 2000 Jul;68(7):4032-9. doi: 10.1128/IAI.68.7.4032-4039.2000. Infect Immun. 2000. PMID: 10858219 Free PMC article.
• Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.
  Elizaga ML, Li SS, Kochar NK, Wilson GJ, Allen MA, Tieu HVN, Frank I, Sobieszczyk ME, Cohen KW, Sanchez B, Latham TE, Clarke DK, Egan MA, Eldridge JH, Hannaman D, Xu R, Ota-Setlik A, McElrath MJ, Hay CM; NIAID HIV Vaccine Trials Network (HVTN) 087 Study Team. Elizaga ML, et al. PLoS One. 2018 Sep 20;13(9):e0202753. doi: 10.1371/journal.pone.0202753. eCollection 2018. PLoS One. 2018. PMID: 30235286 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program